Dyslipidemia and cardiovascular health in childhood nephrotic syndrome-Reference-Cited by-同舟云学术

Dyslipidemia and cardiovascular health in childhood nephrotic syndrome

Published:2019-07-13 Issue:9 Volume:35 Page:1601-1619
ISSN:0931-041X
Container-title:Pediatric Nephrology
language:en
Short-container-title:Pediatr Nephrol

Author:

Hari Pankaj,Khandelwal Priyanka,Smoyer William E.

Publisher

Springer Science and Business Media LLC

Subject

Nephrology,Pediatrics, Perinatology, and Child Health

Link

http://link.springer.com/content/pdf/10.1007/s00467-019-04301-y.pdf

Reference115 articles.

1. Noone DG, Iijima K, Parekh R (2018) Idiopathic nephrotic syndrome in children. Lancet 392:61–74

2. Sinha A, Bagga A (2012) Nephrotic syndrome. Indian J Pediatr 79:1045–1055

3. Vaziri ND (2016) Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences. Kidney Int 90:41–52

4. Expert Panel on Integrated Guidelines for Cardiovascular Health Risk Reduction in Children and Adolescents; National Heart Lung, and Blood Institute (2011) Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 128(Suppl 5):S213–S256

5. Liang K, Vaziri ND (1997) Gene expression of lipoprotein lipase in experimental nephrosis. J Lab Clin Med 130:387–394

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nephrotic syndrome: pathophysiology and consequences;Journal of Nephrology;2023-07-19

2. Association between serum total cholesterol and chronic kidney disease progression in children: results from the KNOW-PedCKD;Pediatric Nephrology;2023-06-20

3. Different Phenotypes of Schimke Immuno-Osseous Dysplasia (SIOD) in Two Sisters with the Same Mutation in the SMARCAL1 Gene;Endocrine, Metabolic & Immune Disorders - Drug Targets;2022-07

4. Lipoproteins and cholesterol homeostasis in paediatric nephrotic syndrome patients;Biochemia medica;2022-06-15

5. Effects of statin therapy and treatment duration on cardiovascular disease risk in patients with nephrotic syndrome: A nested case–control study;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2022-03-03